类有机物
高尿酸血症
黄嘌呤氧化酶
尿酸
嘌呤
次黄嘌呤
黄嘌呤
化学
肝细胞
细胞生物学
体外
生物
生物化学
酶
作者
Chuanli Hou,Yang Hu,Hong Jiang,Zhenzhen Xu,Wanqian Sha,Juncheng Liu,Jiaoyan Ren,Maojin Yao
标识
DOI:10.1016/j.freeradbiomed.2021.11.023
摘要
Hyperuricemia (HUA) is a metabolic disorder caused by abnormal purine metabolism, the prevalence of which has increased worldwide. Here, a 3D organoid culture system for mimicking HUA in vitro was established using cultured human liver organoids. Liver organoids can be generated from single hepatocytes and passaged for several months, retaining key morphological features, functional purine metabolism and global gene expression profile. Furthermore, organoids can be differentiated into hepatocytes with high expression of maturation markers including the hepatocyte nuclear factor-4-alpha (HNF4α), E-cadherin (E-Ca), and albumin (ALB). Importantly, organoids can produce high level of uric acid after xanthine induction which is the substrate of xanthine oxidase. Furthermore, the preclinical application potential of this organoid model was verified by measuring the antihyperuricemic effect of the widely used allopurinol, as well as the reported bioactive substance puerarin. The results demonstrate that this novel organoid model could be used for high-throughput screening of both chemical and food-derived compounds with antihyperuricemic bioactivity.
科研通智能强力驱动
Strongly Powered by AbleSci AI